In the most recent issue of Nature Medicine (April 1, 2019), the blood platelet receptor, glycoprotein Ib a, is shown to be critical for the develop of non-alcoholic fatty liver disease and in particular the progression to liver cancer (https://www.nature.com/articles/s41591-019-0379-5). Jerry Ware, Ph.D., (Professor, Physiology & Biophysics) participated in the study. Dr. Ware and his colleagues have long studied the relevance of glycoprotein Ib a in thrombosis, but the Nature Medicine results highlight the relevance of platelet biology in driving the progression of inflammation and cancer.